Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...

Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...

Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is considered a very rare disease. With C3G, patients have issues with their immune system that cause kidney damage and symptoms ...

This knowledge would help identify individuals who could benefit from early detection programmes, which are essential for a ...

OpenAI just released a report about healthcare drawn from anonymized chatbot conversations. The title could double as one of those depressing single-sentence short stories: “AI as a Healthcare Ally: ...

Bayer and Vanderbilt University Medical Center (VUMC) today announced that they have entered a strategic five-year collaboration agreement to advance innovative therapies from target identification ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

New research shows yoga helps individuals in rehab for opioid addiction recover more quickly and with decreased cravings, ...